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Summary. A comparative study of the cytotoxicity of cucurbitacin E, a natural product, and busulphan on human 
ovarian and stomach cell lines was carried out. The cells were exposed to difji:Jrent concentrations these two 
compounds and c~ll viability was determinedfrom day 0 to day ll. It was observed that cucurbitacin E had a marked 
effect on the ovarian cancer cell line while busulphan showed a similar effect when exposed to the stomach cancer 
cell line. These drug-cell combinations showed a pronounced cell kill exponential curve, leading to the conclusion 
that cucurbitacin E exerts its pinocytic activity on the ovarian cancer cells while busulphan exerts its alkylating 
effict on the stomach cancer cells. 
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Cucurbitacin E and other cucurbitacins are highly 
oxygenated which are found solely in plants 
~ouped under the Cucurbitaceae family, including 
EcbalJium elaterium L. (the squirting, .. cucumber). 
Ecballium. elaterium 1. is a local plant which 
has been used in. folk medicine..as a;. catJbaitic 
199D) and as an emetic (Lanfianco; 
been used in dropsy (penza, 1969}and in; the treatment 
of jaundice (Cini, 1991). 
Experiments on the juice of the plant have shown that 
effective in the treatment of constipation, sinusitis, 
and the prevention of liver disease (Yesiladaet aI., 1988), 
However, . it has been found that the has a low 
therapeutic index (Farnsworth. 1992), but that it contains 
CUCur\)ltaCUlS, including cucurbitacinsRand-E, which have 
antitumour activity. Despite this, when. individual 
cucurbitacins were tested on various. normal the cell 
viability was not affected et al., 1962). 
Cytotoxicity (Gitter et al., 1961) and metabolic studies 
(Shohatet aJ., 1962) were performed on Sarcoma- 180, 
Lettre Erhlich ascites carcinoma and Sarcoma Black 
cucurbitacins D, E and I in mice. There was a 
cytotoxic effect shown by these compounds on 
Sarcoma 180 than on the other two ceU lines. Metabolic 
studies showed that in Ehrlich ascites carcinoma 
the oxygen uptake of cells was more sensitive to the 
action of cucurbitacins than the anaerobic glycolysis. It 
was ObseIVed that the inhibition of the oxidative 
metabolism of the cancer cells by the cucurbitacins was 
related to that ObseIVed by This may be 
due to the fact that the cucurbitacins have a steroid-like 
structure which may influence the permeability of the 
membranes of the cells ibd mitochondria. Combination 
with cucurbitacins and X-rays on transplanted 
tumours in mice (Shobat et al., 1965) was less effective 
on Ehrlich tumour than Sarcoma Black. 
Cucurbitacins B and E showed an effect on cultured 
human nasopharyngeal carcinoma, and Sarcoma 37 
implanted intramuscularly into right hind legs of CAF
1 
mice when these compounds were injected intra-
peritoneally. 
Cucurbitacin E (Figure 1) can exert cytotoxic effect 
either on the cell membrane (Gallily et al., 1962) or on 
the DNA in the nucleus of the cancer cells (Kupchan et 
al., 1973). The cucurbitacin side chain is for 
the ObseIVed cytotoxic activity (Kupchan et al., 1970). 
Busulpban 
Group 
HO Leaving Group 
o Cucurbitadn E 
I. Structures of Busulpban and Cucurbitacin E 
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Busulphan 1) is an alkylating which 
exerts its action by joining two guanine residues on two 
strands of the DNA, leading to cross-linking, in 
turn, prevents the and replication of the DNA 
molecule, thus halting the multiplication of the tumour 
cells et al., 1976). 
Several studies have been carried out on the cell lines 
mentioned different cucurbitacins, but the 
effect of these compounds on ovarian and stomach 
cancer cell lines has not been studied. The present 
was therefore undertaken to examine any effects 
of cucurbitacin E on ovarian and stomach cancer cell 
lines and also to compare the effect of cucurbitacin E 
with that of a used cytotoxic busulphan. 
Experimental Procedures 
Cucurbitacin E was prepared by solvent extraction of the 
fruit of Ecballium elaterium (Lavie et 1958), 
collected from Marsascala (Malta). 52% (w/w) of the 
pure compound was obtained, Its purity was confirmed 
five analytical methods: UV and IR 
spectrophotometry, Melting Point lLC 
and HPLC against a known standard. A specimen is 
deposited at the Institute of Agriculture, University of 
Malta. From a stock solution of 1.8xlO~ 1 in 10 
dilutions 
Busulphan (Myleran@ Wellcome, West Sussex, U.K.) 
500mg tablets were in a mortar and then 
dissolved in RPMI 1640 medium to make a final stock 
solution of 4xlO-4M. I in 10 dilutions were then 
prepared. i! 
stomach and ovarian (OVCAR-3) cell 
lines were obtained from the Department of Anatomy 
University of Malta. These cell lines were cultured and 
subcultured to propagate .the cell lines. The cells were 
grown in RPMI 1640 medium in sterile Nunclon® 
culture flasks and incubated at 37°C in 6% C02. 
Subculturing was performed every seven days 
1988). 
A cell suspension was obtained by detaching !:he 
monolayer from the flask trypsin and resUSJ)endilJlg 
the cells in RPMI medium. Complete cell detachment 
was visualized under a xlOO magnification microscope 
(Diavert Leitz-Wetzlar). 20m! of RPMI medium was 
added to each flask and the cell suspension was 
mixed. A small was withdrawn and cells were 
counted in an Improved Neubauer haemocytometer using 
the method described in the Sigma Cell Culture 
Catalogue (1994). 
The were added on day O. Twenty-eight tubes were 
used in all. 1m! of ovarian cell suspension was added to 
each of fourteen tubes while 1m! of stomach cell 
suspension was added to another fourteen tubes. The 
concentrations of cucurbitacin E used were: 1. 8xlO'6M, 
1.8xlO-7M and L8xl0-8M. The concentrations of 
of Cucurbitllcin £ 
""""'''A,,,,,,,, ... used were: 4xIO~, 4x10·sM and 4xlO'lo:M. 
2m! of the three solutions with different concentrations 
of cucurbitacin E were added to six tubes COIltainilJlg 
ovarian cancer cells, and to six tubes containing stomach 
cancer cells. The same was repeated for 
busulphan. The rest (i.e. four tubes) acted as the control 
tubes in which 2 m! of RPMI medium were added to the 
cancer cell suspension. 
From 7 to 11, the number of viable and non-viable 
cells was counted using a haemocytometer and 0.4% 
trypan blue for the of non~viable cells (Freshney, 
1988). The was followed from day 7 to 1 L as 
it was observed in our laboratory that there was no 
Slgrutlcant lethal effect on the cancer cells from 0 to 
day 7. The five-day day 7 to 11, was sufficient to 
provide information on the cytotoxic of both 
cucurbitacin E and busulphan on the two cancer cell 
lines. A study had shown that the decrease 
in percentage cell viability was not significant after day 
II. 
The cell was calculated using the 
number of viable and non-viable cells obtained. The four 
results were used to obtain an average cell 
viability. The of non-viabile cells was necessary 
to determine the wbidh is ;the concentration of 
cytotoxic compound requiredte kill '50% ofrthecells in 
suspension. The decrease >in ceU viability 'sheuld --depend 
on the activity of the compounds.andnot on the 
limited environmental which include nutrient 
availability in the medium .and the conditions inside the 
incubator. The cell counts .for the tubes treated with the 
rvtntnvir compounds were adjusted the average 
cell count in the control tubes to be 100%. 
Results 
Tumour Cell Growth Inhibition. 2 to 5 show the 
percentage cell viability ,,,,,.,,,,,,,. number of days. for 
ovarian and stomach cancer both tlJeated with 
cucurbitacin E and busulphan. t 
As can be observed from Figure at LBxlO~, 
cucurbitacin E showed a lower terminal percentage log 
cell viability than at l. Bx IO·7M, althougb viability, 
for the latter, was markedly reduced. 3 shows 
that the inhibition. of tumour growth is higher with 
lDcrea:SlDil! busulphan concentration. At the two lower 
(4xIO-llM and 4xlO'I~) of t.. .. ~ .. 1_1 .. ~ 
used, a fall in cell viability was evident after day 
10 while at 4xlO~, a rapid decrease was observed 
after day 9. Figure 4 shows that the effect of 
cucurbitacin E on stomach cancer cells varied with the 
three different concentrations used. At 1 
cucurbitacin there was a rapid decrease in cell 
viability between day Band 9 but a slow steady fall 
thereafter. At L8xlO~ cucurbitacin there was a 
linear decrease in cell viability. At 1.8xlO'7M 
cucurbitacin there was a slow decreases in cell 
viability after 10. Stomach cancer cells tlJeated with 
AttIUd E. tit iii 
4x10~ busulphan (Figure 5) a stepwise 
decrease in viability with time. A considerable decrea:se 
in cell viability after 8 was observed at the three 
concentrations of busulphan used, bnt no further effect at 
4xlO~ and 4xlO-sM was observed after 10. At 
4xlO-sM busulphan a effect was 
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The four different cell-drug combinations were compared 
using the Probit The in the trends 
for these combinations were to be statistically 
significant (p<0.05, 
Cucurbitacin E showed a on the 
ovarian cancer cells than busulphan. It is worth noting 
6 7 8 9 10 11 
Time (Days) 
2: The Percentage Log-of the Adjusted Cell 
Cucurbitacin E(Concentmtions: 1 = l.8x1O:'M, 2 
against Time for ovarian cancer cells exposed to three concentrations of 
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Figure 3; The Percentage Log of the Adjusted CeIJ against Time fur ovarian cancer ceUs exposed to three concentrations of 
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4: The Percentage of the Adjusted Cell Viability . again st . Time for stomach cancer cells to three. concentrations of 
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5: Graph of the Percentage Log of the Adjusted Cell Viability against Time for stomach cancer cells 
OU"UlpnWl (Concentrations: I 4 xIO~, 2 = 4 x IO-8M, 3 4 x lO-HIM) . 
to three concentrations 
that at the concentration of both cytotoxic 
compounds used (1.8xlO~ cucurbitacin E and 4xlO~ 
busulphan), a similar pattern was "observed, 
characterized at day 11. In the 
stomach cancer cells, a cell death was 
obtained with busulphan than with cucwbitacin E. 
Mininwm Median Lethal Concentration. Table 1 shows 
the minimum median lethal concentration for the two 
different cell lines treated with the two cytotoxic drugs. 
Cucuroitacin E showed a minimum LCso of 2.72xlO-1M 
for the ovarian cancer cells at day 10, and a minimum 
of O.5269M for the stomach cancer cells at day 7_ 
For busulphan. the minimum LCso for ovarian cancer 
cells was 9 .14x 104 M at day 9, while that for the stomach 
cancer cells was 2.14xlO-l!M on 10. 
From the values one may note that cucurbitacin E has a 
activity on cancer cells than busulphan 
E < B). On the other hand, 
busulphanshowed a greater effect on the stomach cancer 
ceUs although this occurred on 10 as opposed to the 
Ovarian Cancer I Stomacb CiUlcer 
Cells Cells 
Cucurbitacm E 
2.72xlW7 M M 
R value· 0.8795 0.7575 
BusuJpban 
mLCso 9.143xl0-4 M M 
R value* 0.9006 0.9540 
Table 1. Table showing the roLeS(! for the two different compounds 
and cell lines. *A11 R values are taken at p<O.05, v 4. 
mLCso of cucurbitacin E which was found on day 7. The 
for cucurbitacin E-treated stomach cancer cells is 
too high (0.5269M) to be considered as an effective 
compound. 
Discussion 
Since cucurbitacin E has been shown to have an on 
DNA by alkylation et aJ., and on' the 
cell membrane by the process of (Gallily et 
aI., 1962), it was of interest in this to compare its 
effects on cancer cells with those of and to 
draw some conclusions from the results ob1;ID.neci. 
Tumour Cell Growth Inhibition. The that 
the in vitro cytotoxic of E Was best 
observed on ovarian cancer cell while 6~phan 
showed a greater effect on stomach' cancer cells:' . 
If one considers that cucurbitacin E is taken up by the 
tumour cell by a rate process, there might be 
sufficient uptake at low concentrations to have an 
alkylating effect on the DNA. This might explain the 
greater cytotoxic effect observed for cucurbitacin E on 
ovarian cancer cells at the lowest concentration 
( 1. 8x 1 O·8M) used. Whether this effect is due to the 
process of is still to be determined. 
However, this process is greatly influenced by high 
cucurbitacin E concentrations, where an increase in 
the uptake of fluid inside the cell leads to cell 
blistering and cell death. This was 
observed by GaBBy and co-workers (1962). on four 
cell lines, using elatericin A and B. At high 
concentrations, the effect on the cell membrane is 
more pronounced. 
Busulphan. at a concentration of 4xlO·l~ and 4xlO-llM, 
did not have an effect on the ovarian cancer cells. 
This is known as the tumerostatic effect. At these two 
concentrations, insignificant cytotoxicity was 
observed until 10 after which a decrease in cell 
was observed. At the highest concentration 
used, the same effect was observed until 
9 after which there was a better " .. ""£\',,,,'" 
be the fact that busulphan did 
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not appear to affect the pinocytic activity of the tumour 
cells since cell morphological were not 
observed. The high rate of cell death observed for the 
high concentration might be due to the effects on the 
DNA by alkylation. 
At the lowest concentration (1.8xlO~ ofcucurbitacin E 
a small effect on the stomach cancer line was 
observed, probably due to the limited amount of drug in 
solution. However, at the highest concentration (1.8xlO~ 
a marked effect on cell viability was It can be 
concluded that stomach cancer cells showed marked 
resistance towards cucurbitacin 
ovarian cancer cells toward UUlSWIJII<l~l. 
hand, busulphan showed effective in the 
stomach cancer cells. Although there a great 
reduction in the viable count at concentration 
(4xlO~ used, the 4xlO-llM concentration showed a 
lower end-point. at these two concentrations, 
after day 10, no further inhibition was 
observed. 
It would appear that the of the cytotoxic 
compounds on stomach cancer cells does not depend on 
the pinocytic activity but· on the alkylating effect on the 
DNA since busulphan had a activity than 
cucurbitacin E on these cells. 
It can be concluded from these results that cucurbitacin E 
lacks effect of busulphan but 
activihl of cucurbitacin E. It 
J)O!ilw.ate:a that cucurbitacUr E increases 
the uptake of other agents) 
while the latter exerts its effects inside the cell. The 
effect of cucurbitacin E on the of cell 
membranes (Shohat et ai., 1962) could be due to its 
steroid-like structure which is similiar to that of the cell 
membrane. It should also be stressed that cucurbitacin E 
has an effect on both cell lines, although a minimal one 
on the stomach cancer cells. 
Minimum Median Lethal Concentration. The median 
lethal concentrations (LCso) for cucurbitacin E on the 
ovarian and stomach cancer cells show that for the 
cells the was quite satisfactory and hence 
merits further attention while for stomach cancer cells 
the indicates a lack of sensitivity of these cells 
For busulphan the LCso, for the ovarian cancer cells is 
and so it can be regarded as ineffective for the 
treatment of ovarian cancer. In fact the for 
is 3361 times greater than that for 
cucurbitacin E in these cells. However, the low for 
stomach cancer cells suggests that it can be used. On the 
contrary, the mLCso for busulphan is much smaller than 
that for cucurbitacin E, i.e. the mLCso of the 
about 2.46x1Q7 times greater than the 
busulphan. 
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To substantiate the above further 
investigations would have to be carried out to 
determine the extent of the activity of the two 
cytotoxic agents in vivo, to determine morphological 
_"~~''''''W~ and to detect any DNA aberrations .. 
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